What was the purpose of this 8-K filing?

The purpose of this 8-K filing was to officially announce the expiration and final results of CVS Health Corporation's tender offer for its 6.302% Enhanced Capital Advantaged Preferred Securities.

What specific securities were involved in the tender offer?

The tender offer specifically involved CVS Health Corporation's 6.302% Enhanced Capital Advantaged Preferred Securities.

When did the tender offer expire?

The tender offer expired on December 7, 2011, as announced in the press release attached to this filing.

Where can investors find the detailed results of the tender offer?

Investors can find the detailed final results of the tender offer in the press release dated December 7, 2011, which is included as Exhibit 99.1 to this 8-K filing.

CVS 8-K SEC Disclosure

Summary

CVS Health Corporation (formerly CVS Caremark Corporation) filed an 8-K on December 7, 2011, to announce the results of its tender offer for its 6.302% Enhanced Capital Advantaged Preferred Securities. The tender offer has expired, and the company has provided the final results of this offer. This filing serves to officially inform stakeholders about the conclusion of this financial transaction and its implications for the company's capital structure.

Key Highlights

1CVS Health Corp announced the expiration and final results of its tender offer for 6.302% Enhanced Capital Advantaged Preferred Securities.
2The tender offer has concluded as of December 7, 2011.
3This 8-K filing serves as official notification of the tender offer's outcome.
4The press release detailing the final results is attached as Exhibit 99.1.

CVS HEALTH Corp 8-K Report, Corporate Update (Dec 8, 2011)

Summary

Key Highlights

Frequently Asked Questions